| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2018 | 5,902.00 | 5,956.00 | 5,869.00 | 5,934.00 | 2,638,758 |
| Oct 18, 2018 | 5,870.00 | 5,914.00 | 5,848.00 | 5,878.00 | 1,925,085 |
| Oct 17, 2018 | 5,828.00 | 5,925.00 | 5,804.00 | 5,860.00 | 2,521,553 |
| Oct 16, 2018 | 5,708.00 | 5,773.00 | 5,628.00 | 5,763.00 | 2,297,490 |
| Oct 15, 2018 | 5,543.00 | 5,635.00 | 5,518.00 | 5,619.00 | 2,035,028 |
| Name | AstraZeneca | Epic | AZN |
|---|---|---|---|
| ISIN | GB0009895292 | Currency | GBX |
| Type | Equity | Trading Segment | SET1 |
| Record Status | Active | Trading Status | Closed |
| Industry | Health Care | Sector | Pharmaceuticals & Biotechnology |
| EMS | 300 | Prev Close | 5,934.00 |
| Shares in Issue (m) | 1,266.78 | Market Cap (£m) | 74,233.60 |
| PE Ratio | 24.73 | Div per Share (p) | 202.50 |
| Div Yield | 3.45 | Div Cover | 1.17 |
| EPS | 237.00 | EPS Growth (%) | -14.44 |
| PEG | -1.71 | DPS Growth (%) | -7.49 |
| ROCE | 4.74 | Net Gearing | 68.49 |
| Quick Ratio | 0.62 | Current Ratio | 0.80 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 19 Oct | JP Morgan Cazenove | Overweight | 5,934.00 | 6,500.00 | - | Reiterates |
| 19 Oct | Barclays Capital | Overweight | 5,934.00 | 6,600.00 | - | Reiterates |
| 16 Oct | Shore Capital | Hold | 5,934.00 | - | - | Reiterates |
| 15 Oct | Barclays Capital | Overweight | 5,934.00 | 6,600.00 | - | Reiterates |
| 09 Oct | Barclays Capital | Overweight | 5,934.00 | 6,600.00 | - | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 28 Mar 2018 | Pascal Soriot | Transfer In | 11,998 @ 0.00p | £0.00 |
| 28 Mar 2018 | Marc Dunoyer | Transfer In | 3,768 @ 0.00p | £0.00 |
| 05 Feb 2018 | Philip Broadley | Buy | 415 @ 4,846.00p | £20,110.90 |
| 15 Dec 2017 | Pascal Soriot | Transfer Out | 39,648 @ 0.00p | £0.00 |
| 28 Jul 2017 | Philip Broadley | Buy | 2,300 @ 4,282.00p | £98,486.00 |
